In the pharmaceutical industry, master data management is critical to ensuring the quality, safety, and efficacy of products. It directly affects the internal reporting of product information and can impact regulatory submissions. Inaccurate, inconsistent, or incomplete data included in regulatory submissions can lead to delayed approvals, product recalls, and regulatory penalties.
In this white paper, we outline the principles of master data management and its impact on regulatory affairs. We also provide guidance on how best to integrate master data into your regulatory strategy.
Partnering with a specialized software vendor like Ennov can provide access to a team of experts in the field. Our team can provide guidance and support throughout the entire process, from initial assessment to implementation and ongoing maintenance. Contact us to learn more.